Abstract:BACKGROUND: Squamous cell carcinoma of unknown primary of the head and neck region is a known entity described mainly by retrospective reports. We searched a hospital-based registry to better describe the changing incidence, and to assess diagnostic and treatment strategies.METHODS: The National Comprehensive Cancer Database was queried for head and neck cancers from oropharynx, tonsil, tongue, larynx, hypopharynx primary sites with a designation of clinical T0, representing an unknown primary. Kaplan Meier, Cox multivariate models, and propensity matched cohorts were used to assess significant factors for overall survival.RESULTS: There were 964 cases that met the criteria, and 468 cases with known treatments, staging, and survival data. The incidence increased over time, with the highest rates supported in the last 5 years. In patients who underwent HPV testing, 72% were positive. Patients with AJCC 7<sup>th</sup> clinical N2c or N3 disease had significantly worse outcomes despite the majority receiving neck dissection, radiation, and chemotherapy. Local surgery, compared to incisional or excisional biopsy, had the highest diagnostic yield of finding a primary tumor. In multivariate models, no combination of surgical approach, radiation, or systemic therapy was significantly associated with improved survival. This remained true in 1:1 propensity matched cohorts for age, comorbidities, and clinical nodal burden. In a subset of cN1 patients, combined chemoradiation therapy after excisional biopsy or local surgery was associated with (not statistically significant) improved survival compared to radiation alone (P=0.054).CONCLUSIONS: The incidence of unknown primary head and neck carcinoma is increasing, and current cases have a high proportion of HPV positivity. HPV positivity predicts strongly for a tonsil primary. Local surgery was associated with the highest diagnostic yield. Clinical nodal burden strongly predicts for overall outcome, and type of treatment facility is an important driver of survival. A subset of cN1 patients may benefit from the addition of chemotherapy to radiation.

Updates in head and neck cytopathology: Insights from European Congress of Pathology Short Course

Current role of cytopathology in the molecular and computational era: The perspective of young pathologists

Cytopathology: From its humble beginnings to the birth of the cytopathology fellowship

Molecular techniques in cytopathology practice

Clinical update on head and neck cancer: molecular biology and ongoing challenges

Oncogenes, molecular biology and the head and neck surgeon.

Advanced imaging technology applications in cytology

Intraoperative cytology of CNS tumours: Challenges associated with an evolving landscape

COVID and cytopathology training: Impact and innovations

[Special tumor entities in the head and neck region: nasopharyngeal, salivary gland, and thyroid cancer]

Update zu HPV-assoziierten Kopf-Hals-Karzinomen – Highlights der ASCO-Jahrestagung 2024

Evolving concepts in thyroid cytology

Molecular Markers in the World Health Organization Classification of Head and Neck Tumors, Fifth Edition

Copenhagen Basic Head & Neck Ultrasound Course

Towards Artificial Intelligence Applications in Next Generation Cytopathology

The Next Chapter in Cancer Diagnostics: Advances in HPV-Positive Head and Neck Cancer

EGFR analysis: Current evidence and future directions

Methods for Nuclei Detection, Segmentation, and Classification in Digital Histopathology: A Review—Current Status and Future Potential

Molecular Pathways and Druggable Targets in Head and Neck Squamous Cell Carcinoma

Insights into metastatic roadmap of head and neck cancer squamous cell carcinoma based on clinical, histopathological and molecular profiles

Squamous cell carcinoma of the head and neck with unknown primary: trends and outcomes from a hospital-based registry